A minimal physiological model of thiopental distribution kinetics based on a multiple indicator approach

Drug Metabolism and Disposition

Volumn 35, Issue 9, 2007, Pages 1525-1532

  Weiss, Michael ^a   Krejcie, Tom C ^b   Avram, Michael J ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; PHENAZONE; THIOPENTAL;

ADIPOSE TISSUE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WATER; CONTROLLED STUDY; DOG; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL;

ADIPOSE TISSUE; ALGORITHMS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRINE; BODY WATER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; DIFFUSION; DOGS; HYPNOTICS AND SEDATIVES; INDOCYANINE GREEN; MALE; MODELS, STATISTICAL; PULMONARY CIRCULATION; THIOPENTAL; TISSUE DISTRIBUTION;

CANIS FAMILIARIS; RATTUS;

EID: 34548100650     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.014209     Document Type: Article

References (29)

1. Avram MJ and Krejcie TC (1987) Determination of sodium pentobarbital and either sodium methohexital or sodium thiopental in plasma by high performance liquid chromatography with ultraviolet detection. J Chromatogr 414:484-491.
2. Avram MJ and Krejcie TC (2003) Using front-end kinetics to optimize target-controlled drug infusions. Anesthesiology 99:1078 -1086.
3. Avram MJ, Krejcie TC, and Henthorn TK (2002) The concordance of early antipyrine and thiopental distribution kinetics. J Pharmacol Exp Ther 302:594-600.
4. Avram MJ, Krejcie TC, Henthorn TK, and Niemann CU (2004) β-Adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution. J Pharmacol Exp Ther 311:617-624.
5. Björkman S (2002) Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed? J Pharm Pharmacol 54:1237-1245.
6. Brodie BB, Bernstein E, and Mark LC (1952) The role of body fat in limiting the duration of action of thiopental. J Pharmacol Exp Ther 105:421-426.
7. Brown RB, Delp MD, Lindstedt SL, Rhomberg LR, and Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407-484.
8. Coppack SW (2005) Adipose tissue changes in obesity. Biochem Soc Trans 33:1049-1052.
9. Crank J (1975) The Mathematics of Diffusion, 2nd ed. p. 326, Oxford University Press, Oxford, UK.
10. D'Argenio DZ and Schumitzky A (1997) ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software, Biomedical Simulations Resource, Los Angeles, CA.
11. Ebling WF, Wada DR, and Stanski DR (1994) From piecewise to full physiologic pharmacokinetic modeling: applied to thiopental disposition in the rat. J Pharmacokinet Biopharm 22:259-292.
12. Henthorn TK, Avram MJ, Krejcie TC, Shanks CA, Asada A, and Kaczynski DA (1992) Minimal compartmental model of circulatory mixing of indocyanine green. Am J Physiol 262:H903-H910.
13. Jung D, Mayersohn M, Perrier D, Calkins J, and Saunders R (1982) Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 56:269-274.
14. Krejcie TC and Avram MJ (1999) What determines anesthetic induction dose? It's the front-end kinetics, doctor! Anesth Analg 89:541-544.
15. Krejcie TC, Henthorn TK, Gentry WB, Niemann CU, Enders-Klein C, Shanks CA, and Avram MJ (1999) Modifications of blood volume alter the disposition of markers of blood volume, extracellular fluid, and total body water. J Pharmacol Exp Ther 291:1308-1316.
16. Krejcie TC, Henthorn TK, Niemann CU, Klein C, Gupta DK, Gentry WB, Shanks CA, and Avram MJ (1996a) Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly. J Pharmacol Exp Ther 278:1050-1057.
17. Krejcie TC, Jacquez JA, Avram MJ, Niemann CU, Shanks CA, and Henthorn TK (1996b) Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs. J Pharmacokinet Biopharm 24:569-588.
18. Price HL (1960) A dynamic concept of the distribution of thiopental in the human body. Anesthesiology 21:40-45.
19. Schalla M and Weiss M (1999) Pharmacokinetic curve fitting using numerical inverse Laplace transformation. Eur J Pharm Sci 7:305-309.
20. Shideman FE, Gould TC, Winters WD, Peterson RC, and Wilner WK (1953) The distribution and in vivo rate of metabolism of thiopental. J Pharmacol Exp Ther 107:368-378.
21. Upton RN and Ludbrook GL (1999) A model of the kinetics and dynamics of induction of anaesthesia in sheep: variable estimation for thiopental and comparison with propofol. Br J Anaesth 82:890-899.
22. Wada DR, Bjorkman S, Ebling WF, Harashima H, Harapat SR, and Stanski DR (1997) Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87:884-899.
23. Weiss M (1999a) Pharmacokinetics in organs and the intact body: model validation and reduction. Eur J Pharm Sci 7:119-127.
24. Weiss M (1999b) Cellular pharmacokinetics: Effects of cytoplasmic diffusion and binding on organ transit time distribution. J Pharmacokinet Biopharm 27:233-255.
25. Weiss M, Hübner GH, Hübner GI, and Teichmann W (1996) Effects of cardiac output on disposition kinetics of sorbitol: recirculatory modelling. Br J Clin Pharmacol 41:261-268.
26. Weiss M, Krejcie TC, and Avram MJ (2006) Transit time dispersion in the pulmonary and systemic circulation: effects of cardiac output and solute diffusivity. Am J Physiol 291:H861-H870.
27. Weiss M, Krejcie TC, and Avram MJ (2007) Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog. J Pharm Sci 96:913-926.
28. Weiss M and Pang KS (1992) Dynamics of drug distribution. I. Role of the second and third curve moments. J Pharmacokinet Biopharm 20:253-278.
29. Weiss M and Roberts MS (1996) Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb. J Pharmacokinet Biopharm 24:173-196.